Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Hemophilia is a rare, inherited disorder in which blood doesn’t clot normally due to the lack of sufficient blood clotting factor. Clotting factor is a protein required for blood clotting to occur normally.
Novel treatments for people suffering from hemophilia and other different bleeding problems has evolved over the past. Hemostasis requires a specific missing plasma protein to prevent unnecessary bleeding, they are named as different factors in the blood. Furthermore, these proteins are contained in concentrate products of lyophilized factor. The analysis in the report describes the purity and viral safety issues for most of the coagulation products currently available along with the market potential. A prompt treatment is required for therapeutic management of bleeding disorders during the bleeding episodes to minimize complications ascending from accumulation of blood in joint spaces that may result in compartment syndrome and have its own complication in health of an individual. There are number of treatment regimens available in the form of non-complicated and complicated bleeding episodes.
The report details the trend, potential and market size of Hemophillia A and B Therapeutics Materials market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Hemophillia A and B Therapeutics Materialsmarket, defines the market attractiveness level of Hemophillia A and B Therapeutics Materials market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Hemophillia A and B Therapeutics Materials industry, describes the types of Hemophillia A and B Therapeutics Materials market, the applications of major players and the market size, and deeply analyzes the current situation of the global Hemophillia A and B Therapeutics Materials market and the development prospects and opportunities of Hemophillia A and B Therapeutics Materials industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Hemophillia A and B Therapeutics Materials market in Chapter 13.
By Player:
Arsia therapeutics
Sangamo Therapeutics, Inc
Spark Therapeutics, Inc
Alnylam Pharmaceuticals, Inc
By Type:
Desmopressin
Octocogalfa
Nonacogalfa
Others
By End-User:
Clinics
Hospitals
Ambulatory Surgical Centers
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Hemophillia A and B Therapeutics Materials Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Hemophillia A and B Therapeutics Materials Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Hemophillia A and B Therapeutics Materials Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Hemophillia A and B Therapeutics Materials Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Hemophillia A and B Therapeutics Materials Market Analysis and Outlook to 2022
-
7.1 Global Hemophillia A and B Therapeutics Materials Consumption (2017-2022)
-
7.2 United States Hemophillia A and B Therapeutics Materials Consumption (2017-2022)
-
7.3 Europe Hemophillia A and B Therapeutics Materials Consumption (2017-2022)
-
7.4 China Hemophillia A and B Therapeutics Materials Consumption (2017-2022)
-
7.5 Japan Hemophillia A and B Therapeutics Materials Consumption (2017-2022)
-
7.6 India Hemophillia A and B Therapeutics Materials Consumption (2017-2022)
-
7.7 South Korea Hemophillia A and B Therapeutics Materials Consumption (2017-2022)
8 Region and Country-wise Hemophillia A and B Therapeutics Materials Market Analysis and Outlook to 2028
-
8.1 Global Hemophillia A and B Therapeutics Materials Consumption Forecast (2022-2028)
-
8.2 United States Hemophillia A and B Therapeutics Materials Consumption Forecast (2022-2028)
-
8.3 Europe Hemophillia A and B Therapeutics Materials Consumption Forecast (2022-2028)
-
8.4 China Hemophillia A and B Therapeutics Materials Consumption Forecast (2022-2028)
-
8.5 Japan Hemophillia A and B Therapeutics Materials Consumption Forecast (2022-2028)
-
8.6 India Hemophillia A and B Therapeutics Materials Consumption Forecast (2022-2028)
-
8.7 South Korea Hemophillia A and B Therapeutics Materials Consumption Forecast (2022-2028)
9 Global Hemophillia A and B Therapeutics Materials Market Outlook by Types and Applications to 2022
-
9.1 Global Hemophillia A and B Therapeutics Materials Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Desmopressin Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Octocogalfa Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Nonacogalfa Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Hemophillia A and B Therapeutics Materials Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)
10 Global Hemophillia A and B Therapeutics Materials Market Outlook by Types and Applications to 2028
-
10.1 Global Hemophillia A and B Therapeutics Materials Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Desmopressin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Octocogalfa Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Nonacogalfa Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Hemophillia A and B Therapeutics Materials Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)
11 Global Hemophillia A and B Therapeutics Materials Import and Export Analysis (Top 5 Countries)
-
11.1 Global Hemophillia A and B Therapeutics Materials Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Hemophillia A and B Therapeutics Materials Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Hemophillia A and B Therapeutics Materials Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Hemophillia A and B Therapeutics Materials Market Competitive Analysis
-
14.1 Arsia therapeutics
-
14.1.1 Arsia therapeutics Company Details
-
14.1.2 Arsia therapeutics Hemophillia A and B Therapeutics Materials Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Arsia therapeutics Hemophillia A and B Therapeutics Materials Product and Service
-
14.2 Sangamo Therapeutics, Inc
-
14.2.1 Sangamo Therapeutics, Inc Company Details
-
14.2.2 Sangamo Therapeutics, Inc Hemophillia A and B Therapeutics Materials Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Sangamo Therapeutics, Inc Hemophillia A and B Therapeutics Materials Product and Service
-
14.3 Spark Therapeutics, Inc
-
14.3.1 Spark Therapeutics, Inc Company Details
-
14.3.2 Spark Therapeutics, Inc Hemophillia A and B Therapeutics Materials Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Spark Therapeutics, Inc Hemophillia A and B Therapeutics Materials Product and Service
-
14.4 Alnylam Pharmaceuticals, Inc
-
14.4.1 Alnylam Pharmaceuticals, Inc Company Details
-
14.4.2 Alnylam Pharmaceuticals, Inc Hemophillia A and B Therapeutics Materials Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Alnylam Pharmaceuticals, Inc Hemophillia A and B Therapeutics Materials Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Hemophillia A and B Therapeutics Materials
-
Figure Hemophillia A and B Therapeutics Materials Picture
-
Table Global Hemophillia A and B Therapeutics Materials Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Hemophillia A and B Therapeutics Materials Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Hemophillia A and B Therapeutics Materials Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Hemophillia A and B Therapeutics Materials Consumption by Country (2017-2022)
-
Figure United States Hemophillia A and B Therapeutics Materials Consumption and Growth Rate (2017-2022)
-
Table Europe Hemophillia A and B Therapeutics Materials Consumption and Growth Rate (2017-2022)
-
Figure China Hemophillia A and B Therapeutics Materials Consumption and Growth Rate (2017-2022)
-
Figure Japan Hemophillia A and B Therapeutics Materials Consumption and Growth Rate (2017-2022)
-
Figure India Hemophillia A and B Therapeutics Materials Consumption and Growth Rate (2017-2022)
-
Figure South Korea Hemophillia A and B Therapeutics Materials Consumption and Growth Rate (2017-2022)
-
Figure Global Hemophillia A and B Therapeutics Materials Consumption Forecast by Country (2022-2028)
-
Figure United States Hemophillia A and B Therapeutics Materials Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Hemophillia A and B Therapeutics Materials Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Hemophillia A and B Therapeutics Materials Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Hemophillia A and B Therapeutics Materials Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Hemophillia A and B Therapeutics Materials Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Hemophillia A and B Therapeutics Materials Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Desmopressin Consumption and Growth Rate (2017-2022)
-
Figure Global Octocogalfa Consumption and Growth Rate (2017-2022)
-
Figure Global Nonacogalfa Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)
-
Figure Global Desmopressin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Octocogalfa Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Nonacogalfa Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Hemophillia A and B Therapeutics Materials Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Hemophillia A and B Therapeutics Materials Export by Region (Top 5 Countries) (2017-2028)
-
Table Arsia therapeutics (Foundation Year, Company Profile and etc.)
-
Table Arsia therapeutics Hemophillia A and B Therapeutics Materials Sales, Price, Value and Gross Profit (2017-2022)
-
Table Arsia therapeutics Hemophillia A and B Therapeutics Materials Product and Service
-
Table Sangamo Therapeutics, Inc (Foundation Year, Company Profile and etc.)
-
Table Sangamo Therapeutics, Inc Hemophillia A and B Therapeutics Materials Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sangamo Therapeutics, Inc Hemophillia A and B Therapeutics Materials Product and Service
-
Table Spark Therapeutics, Inc (Foundation Year, Company Profile and etc.)
-
Table Spark Therapeutics, Inc Hemophillia A and B Therapeutics Materials Sales, Price, Value and Gross Profit (2017-2022)
-
Table Spark Therapeutics, Inc Hemophillia A and B Therapeutics Materials Product and Service
-
Table Alnylam Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)
-
Table Alnylam Pharmaceuticals, Inc Hemophillia A and B Therapeutics Materials Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alnylam Pharmaceuticals, Inc Hemophillia A and B Therapeutics Materials Product and Service
-
